Envoy Medical - Class A (COCH) closed at $6.63 on October 30, 2026, up 2.0% from the previous close, on volume of 48,364 shares (30-day average 90,189).
Data as of October 30, 2026.
Newsfile (Wed, 28-Oct 8:31 AM ET)
Envoy Medical Completes 1-for-10 Reverse Stock Split
TipRanks (Tue, 27-Oct 8:58 AM ET)
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Newsfile (Tue, 27-Oct 8:31 AM ET)
Envoy Medical Announces Reverse Stock Split
Newsfile (Thu, 22-Oct 8:31 AM ET)
Newsfile (Tue, 20-Oct 8:31 AM ET)
Newsfile (Mon, 12-Oct 8:30 AM ET)
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Newsfile (Tue, 22-Sep 8:30 AM ET)
Newsfile (Wed, 2-Sep 8:30 AM ET)
Newsfile (Mon, 10-Aug 8:01 AM ET)
COCH Shares Rally as 12-Month Study Shows Acclaim Implant Achieves 38-Point Gain in Word Recognition
Market Chameleon (Tue, 14-Jul 6:29 AM ET)
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.
As of October 30, 2026, COCH stock price climbed to $6.63 with 48,364 million shares trading.
COCH has a beta of 0.94, meaning it tends to be less sensitive to market movements. COCH has a correlation of 0.02 to the broad based SPY ETF.
COCH has a market cap of $51.31 million. This is considered a Micro Cap stock.
Last quarter Envoy Medical - Class A reported $51,000 in Revenue and -$.07 earnings per share. This fell short of revenue expectation by $-25,000 and exceeded earnings estimates by $.01.
In the last 3 years, COCH traded as high as $114.60 and as low as $3.63.
The top ETF exchange traded funds that COCH belongs to (by Net Assets): VXF, VTI.
COCH has underperformed the market in the last year with a return of -11.5%, while the SPY ETF gained +12.3%. In the last 3 month period, COCH fell short of the market, returning -0.5%, while SPY returned +2.1%. However, in the most recent 2 weeks COCH has outperformed the stock market by returning -0.7%, while SPY returned -1.0%.
COCH support price is $6.08 and resistance is $6.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.
